These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 35263900
21. Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report. Jevtic D, Dharmah U, Bahar M. J Investig Med High Impact Case Rep; 2023; 11():23247096231217829. PubMed ID: 38097369 [Abstract] [Full Text] [Related]
25. Juvenile dermatomyositis: a 20-year retrospective analysis of treatment and clinical outcomes. Sun C, Lee JH, Yang YH, Yu HH, Wang LC, Lin YT, Chiang BL. Pediatr Neonatol; 2015 Feb; 56(1):31-9. PubMed ID: 24985888 [Abstract] [Full Text] [Related]
26. Erythroderma and extensive poikiloderma - a rare initial presentation of dermatomyositis: a case report. Herath HMMTB, Keragala BSDP, Pahalagamage SP, Janappriya GHCC, Kulatunga A, Gunasekera CN. J Med Case Rep; 2018 Mar 24; 12(1):83. PubMed ID: 29571300 [Abstract] [Full Text] [Related]
27. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report. Kishi T, Tani Y, Okiyama N, Mizuochi K, Ichimura Y, Harigai M, Nagata S, Miyamae T. Pediatr Rheumatol Online J; 2021 Mar 19; 19(1):34. PubMed ID: 33740993 [Abstract] [Full Text] [Related]
28. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Brown VE, Pilkington CA, Feldman BM, Davidson JE, Network for Juvenile Dermatomyositis, Paediatric Rheumatology European Society (PReS). Rheumatology (Oxford); 2006 Aug 19; 45(8):990-3. PubMed ID: 16467366 [Abstract] [Full Text] [Related]
29. Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review. Paik JJ, Lubin G, Gromatzky A, Mudd PN, Ponda MP, Christopher-Stine L. Clin Exp Rheumatol; 2023 Mar 19; 41(2):348-358. PubMed ID: 35766013 [Abstract] [Full Text] [Related]
34. [Dermatomyositis and juvenile dermatomyositis]. Dressler F, Maurer B. Z Rheumatol; 2023 Apr 19; 82(3):233-245. PubMed ID: 35486206 [Abstract] [Full Text] [Related]
35. Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N, Buoncompagni A, Pilkington C, Maillard S, Oliveira SK, Sztajnbok F, Cuttica R, Corona F, Katsicas MM, Russo R, Ferriani V, Burgos-Vargas R, Solis-Vallejo E, Bandeira M, Baca V, Saad-Magalhaes C, Silva CA, Barcellona R, Breda L, Cimaz R, Gallizzi R, Garozzo R, Martino S, Meini A, Stabile A, Martini A, Ravelli A. Clin Exp Rheumatol; 2011 Apr 19; 29(1):117-24. PubMed ID: 21345298 [Abstract] [Full Text] [Related]
36. Profile of Pediatric Idiopathic Inflammatory Myopathies from a Tertiary Care Center of Eastern India. Sarkar S, Mondal T, Saha A, Mondal R, Datta S. Indian J Pediatr; 2017 Apr 19; 84(4):299-306. PubMed ID: 28251541 [Abstract] [Full Text] [Related]
37. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management. Walling HW, Gerami P, Sontheimer RD. Paediatr Drugs; 2010 Apr 19; 12(1):23-34. PubMed ID: 20034339 [Abstract] [Full Text] [Related]
38. An elusive case of dermatomyositis. Ahsan T, Erum U. J Pak Med Assoc; 2017 Nov 19; 67(11):1756-1758. PubMed ID: 29171576 [Abstract] [Full Text] [Related]